Procalcitonin; a feasible biomarker for severe bacterial infections in Obstetrics and Gynecology?

Benita Tujula^{1

2}, Hannu Kokki², Juha Räsänen³, Merja Kokki¹

Affiliations

¹ Department of Anesthesia and Operative Services, Kuopio University Hospital, Kuopio, Finland.
² School of Medicine, University of Eastern Finland, Kuopio, Finland.
³ Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.

Free article

Editorial

Benita Tujula et al. Acta Obstet Gynecol Scand. 2018 May.

Free article

. 2018 May;97(5):505-506.

doi: 10.1111/aogs.13346.

Benita Tujula^{1

2}, Hannu Kokki², Juha Räsänen³, Merja Kokki¹

¹ Department of Anesthesia and Operative Services, Kuopio University Hospital, Kuopio, Finland.
² School of Medicine, University of Eastern Finland, Kuopio, Finland.
³ Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.

No abstract available

Comment in

The role of procalcitonin in the diagnosis and management of infections in the field of obstetrics and gynecology.
Levin G, Rottenstreich A. Levin G, et al. Acta Obstet Gynecol Scand. 2018 Sep;97(9):1148. doi: 10.1111/aogs.13376. Epub 2018 May 29. Acta Obstet Gynecol Scand. 2018. PMID: 29772055 No abstract available.